Graca V. Esteves
Santa Maria, Portugal
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Improved real-world outcomes of patients with acute promyelocytic leukaemia treated with first-line arsenic trioxide in specialized centres in Portugal through a 24/7 phone-based referral.
Journal: British journal of haematology
Published: March 03, 2026
Efficacy and safety of isatuximab subcutaneous plus carfilzomib and dexamethasone in patients with relapsed/refractory multiple myeloma: results of the Phase 2 study IZALCO.
Journal: Blood cancer journal
Published: July 08, 2025
Disseminated intravascular coagulation score evolution in 48 h predicts early death in acute promyelocytic leukemia patients.
Journal: European journal of haematology
Published: October 21, 2023
Diagnosis and referral of patients with AL amyloidosis in Portugal: results from a Delphi panel.
Journal: Porto biomedical journal
Published: April 13, 2023
Predictors of very early death in acute promyelocytic leukemia: a retrospective real-world cohort study.
Journal: Annals of hematology
Published: April 09, 2023
Multiple Myeloma Treatment Guidelines by the Portuguese Group of Multiple Myeloma
Journal: Acta medica portuguesa
Published: September 02, 2022
Screening a Targeted Panel of Genes by Next-Generation Sequencing Improves Risk Stratification in Real World Patients with Acute Myeloid Leukemia.
Journal: Cancers
Published: May 25, 2022
International Myeloma Working Group risk stratification model for smoldering multiple myeloma (SMM).
International Myeloma Working Group risk stratification model for smoldering multiple myeloma (SMM).
Journal: Blood cancer journal
Published: June 08, 2020
Necrotizing fasciitis of the vulva due to carbapenem-resistant Enterobacteriaceae as a complication of acute myeloid leukemia treatment: a case report.
Journal: Journal of medical case reports
Published: November 01, 2019
Multiple myeloma in elderly patients-a Portuguese multicentric real-life study.
Journal: Annals of hematology
Published: May 20, 2018
Lenalidomide is effective and safe for the treatment of patients with relapsed multiple myeloma and very severe renal impairment.
Journal: Annals of hematology
Published: December 08, 2015
Immune status of high-risk smoldering multiple myeloma patients and its therapeutic modulation under LenDex: a longitudinal analysis.
Journal: Blood
Published: October 08, 2015
Last Updated: 09/26/2026